How useful is thyroid function testing in patients with recent-onset atrial fibrillation?

Archives of Internal Medicine

Volumn 156, Issue 19, 1996, Pages 2221-2224

  Krahn, Andrew D ^a   Klein, George J ^a   Kerr, Charles R ^b   Boone, John ^b   Sheldon, Robert ^c   Green, Martin ^d   Talajic, Mario ^e   Wang, Xiaohua ^b   Connolly, Stuart ^f  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c UNIVERSITY OF CALGARY   (Canada)

^d UNIVERSITY OF OTTAWA   (Canada)

^e MONTREAL HEART INSTITUTE   (Canada)

^f MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CLINICAL TRIAL; FEMALE; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HIGH RISK PATIENT; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; SCREENING; THYROID FUNCTION TEST; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL;

EID: 0029807641     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.156.19.2221     Document Type: Article

References (18)

1. 131I. OJM. 1959;28:347-369.
2. Summers VK, Surtess SJ. Thyrotoxicosis and heart disease. Acta Med Scand. 1961;169:661-671.
3. Ikram H. The nature and prognosis of thyrotoxic heart disease. QJM. 1985; 54:19-28.
4. Ronnov-Jensen V, Kirkegard C. Hyperthyroidism: a disease of old age? BMJ. 1973;1:41-43.
5. Agner T, Almdal T, Thorsteinsson B, Agner E. A reevaluation of atrial fibrillation in thyrotoxicosis. Dan Med Bull. 1984;31:157-159.
6. Iwasaki T, Naka M, Hiramatsu K, et al. Echocardiographic studies on the relationship between atrial fibrillation and enlargement in patients with hyperthyroidism of Graves disease. Cardiology. 1989;76:10-17.
7. Petersen P, Hansen JM. Stroke in thyrotoxicosis with atrial fibrillation. Stroke. 1988;19:15-18.
8. Freedberg AS, Papp JG, Vaughan Williams EM. The effect of altered thyroid state on atrial intracellular potentials. J Physiol (Lond). 1970;207:357-369.
9. Bilezekien JP, Loeb JN. The influence of hyperthyroidism and hypothyroidism on α- and β-adrenergic receptor systems and adrenergic responsiveness. Endocr Rev. 1983;4:378-388.
10. Levey GS, Klein I. Catecholamine-thyroid hormone interactions and the cardiovascular manifestations of hyperthyroidism. Am J Med. 1990;88:642-646.
11. Krahn AD, Manfreda J, Tate R, Mathewson FAL, Cuddy TE. Atrial fibrillation: incidence and risk factors: Manitoba Follow-up Study. Am J Med. 1995;98: 476-484.
12. Kannel WB, Abbott RD, Savage DD, McNamara PM. Epidemiologic features of chronic atrial fibrillation: the Framingham Study. N Engl J Med. 1982;306: 1018-1022.
13. Ciaccheri M, Cecchi F, Arcangelli C, Dolara A, Zuppiroli A, Pieroni C. Occult thyrotoxicosis in patients with chronic and paroxysmal isolated atrial fibrillation. Clin Cardiol. 1984;7:413-416.
14. Giladi M, Aderka D, Zeligman-Melatzki L, Finkelstein A, Ayalon D, Levo Y. Is idiopathic atrial fibrillation caused by occult thyrotoxicosis? a study of one hundred consecutive patients with atrial fibrillation. Int J Cardiol. 1991;30:309-313.
15. Tajiri J, Hamasaki S, Shimada T, et al. Masked thyroid dysfunction among elderly patients with atrial fibrillation. Jpn Heart J. 1986;27:183-190.
16. Cobler JL, Williams ME, Greenland P. Thyrotoxicosis in institutionalized elderly patients with atrial fibrillation. Arch Intern Med. 1984;144:1758-1760.
17. Sawin CT, Geller A, Wolf PA, et al. Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. N Engl J Med. 1994;331: 1249-1252.
18. Tunbridge WMG, Evered DC, Hall R, et al. The spectrum of thyroid disease in a community: the Wickham Survey. Clin Endocrinol (Oxf). 1977;7:481-493.